Literature DB >> 3024885

Expression of Tac antigen in B cell lymphomas.

G Laurent, T Al Saati, D Olive, J C Laurent, P Poncelet, G Delsol.   

Abstract

In a series of 55 cases of B cell derived non-Hodgkin's lymphoma the reactivity of two distinct anti-Tac monoclonal antibodies was examined using a sensitive immunoperoxidase technique on cryostat sections. Eighteen out of the thirty-five cases of B cell lymphomas of low or intermediate grade of malignancy were found to be reactive while six out of 20 cases of high-grade malignancy lymphomas showed a positive immunostaining. No correlation was found between anti-Tac reactivity and surface immunoglobulin phenotype, T65 antigen, or calla expression. These findings showed that IL2 receptor expression is not restricted to activated T cells, and raise the question of the possible role of IL2 in the regulation of malignant B cell clone expansion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024885      PMCID: PMC1542297     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Use of a panel of monoclonal antibodies for the diagnosis of hairy cell leukaemia. An immunocytochemical study of 36 cases.

Authors:  B Falini; K Pulford; W N Erber; D N Posnett; G Pallesen; R Schwarting; L Annino; A Cafolla; S Canino; A Mori
Journal:  Histopathology       Date:  1986-07       Impact factor: 5.087

2.  Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies.

Authors:  N Rebaï; B Malissen
Journal:  Tissue Antigens       Date:  1983-08

3.  Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis.

Authors:  H Stein; B Uchánska-Ziegler; J Gerdes; A Ziegler; P Wernet
Journal:  Int J Cancer       Date:  1982-03-15       Impact factor: 7.396

4.  Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line.

Authors:  D L Urdal; C J March; S Gillis; A Larsen; S K Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  A 55,000 Mr surface antigen on activated human T lymphocytes defined by a monoclonal antibody.

Authors:  M E Hemler; B Malissen; N Rebai; A Liabeuf; C Mawas; F M Kourilsky; J L Strominger
Journal:  Hum Immunol       Date:  1983-10       Impact factor: 2.850

6.  Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.

Authors:  T Miyawaki; S Ohzeki; N Ikuta; H Seki; K Taga; N Taniguchi
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

Authors:  S J Korsmeyer; W C Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; W J Leonard; E S Jaffe; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.

Authors:  R J Robb; W C Greene
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

9.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  7 in total

1.  The proliferation rate of T and B lymphocytes in cerebrospinal fluid.

Authors:  R S Thomas; W Beuche; K Felgenhauer
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

2.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  IL-2 mRNA expression in Tac-positive malignant lymphomas.

Authors:  M Peuchmaur; D Emilie; M C Crevon; P Solal-Celigny; M C Maillot; G Lemaigre; P Galanaud
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

4.  Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.

Authors:  L Kopper; A Bánkfalvi; R Mihalik; K Páloczi; M Benczur; K Lapis
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.

Authors:  H J Schuurman; W Huppes; L F Verdonck; J Van Baarlen; J A Van Unnik
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

6.  Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.

Authors:  H Tesch; A Günther; H Abts; M Jücker; S Klein; G R Krueger; V Diehl
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers.

Authors:  D Schlaifer; G Laurent; S Chittal; T Tsuruo; S Soues; C Muller; J Y Charcosset; C Alard; P Brousset; C Mazerrolles
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.